| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 37,0 M € | +26.2% | 29,3 M € | +27.8% | 22,9 M € | +1.7% | 22,6 M € | +11.2% | 20,3 M € | -1.5% | 20,6 M € | -13.5% | 23,8 M € | -22.1% | 30,6 M € | +136.4% | 12,9 M € | -18.7% | 15,9 M € | -12.4% | 18,2 M € | -11.9% | 20,6 M € | -7.6% | 22,3 M € | +43.2% | 15,6 M € | -27.4% | 21,5 M € | +17.2% | 18,3 M € | +107.8% | 8,8 M € | -28.4% | 12,3 M € | +34.2% | 9,2 M € | +4.2% | 8,8 M € | |
| EBITDA | 840,1 k € | +38.2% | 607,7 k € | +49.1% | 407,7 k € | +20.4% | 338,6 k € | -24.2% | 446,5 k € | +27.5% | 350,3 k € | -26.1% | 473,7 k € | -22.8% | 613,4 k € | +219.1% | 192,2 k € | -52.2% | 401,9 k € | -52.5% | 846,4 k € | +215.1% | 268,6 k € | -40.5% | 451,8 k € | +146.8% | 183,1 k € | -49.7% | 364,2 k € | +67.5% | 217,4 k € | +203.3% | 71,7 k € | -75.2% | 289,2 k € | +295.9% | 73,0 k € | +77.9% | 41,1 k € | |
| Operating profit | 840,1 k € | +38.2% | 607,7 k € | +49.1% | 407,7 k € | +20.4% | 338,6 k € | -24.2% | 446,5 k € | +29.1% | 346,0 k € | -26.3% | 469,4 k € | -22.9% | 609,1 k € | +225.6% | 187,1 k € | -52.9% | 396,9 k € | -52.8% | 841,4 k € | +219.1% | 263,7 k € | -41.0% | 446,9 k € | +147.4% | 180,6 k € | -50.4% | 364,2 k € | +67.5% | 217,4 k € | +203.3% | 71,7 k € | -74.9% | 285,8 k € | +311.5% | 69,5 k € | +72.3% | 40,3 k € | |
| Profit/loss | 614,3 k € | +34.4% | 457,3 k € | +11.8% | 409,0 k € | +192.4% | 139,9 k € | -60.5% | 354,5 k € | +58.2% | 224,1 k € | -15.8% | 266,1 k € | -29.0% | 374,9 k € | +209.7% | 121,0 k € | -54.7% | 267,2 k € | -20.8% | 337,3 k € | +120.3% | 153,2 k € | -46.4% | 285,5 k € | +165.0% | 107,8 k € | -55.5% | 242,2 k € | +102.0% | 119,9 k € | +164.2% | 45,4 k € | -61.3% | 117,2 k € | +327.0% | 27,4 k € | +67.4% | 16,4 k € | |
| Equity | 1,1 M € | +11.7% | 977,9 k € | +6.2% | 920,6 k € | +13.4% | 811,6 k € | -6.9% | 871,8 k € | +6.7% | 817,3 k € | +3.0% | 793,1 k € | +9.1% | 727,1 k € | -3.3% | 752,2 k € | +2.9% | 731,2 k € | +10.1% | 664,0 k € | +26.1% | 526,7 k € | -21.8% | 673,5 k € | +53.8% | 438,0 k € | +1.8% | 430,2 k € | +128.7% | 188,1 k € | -55.1% | 419,0 k € | +12.1% | 373,6 k € | +45.7% | 256,5 k € | +12.0% | 229,0 k € | |
| Total assets | 5,0 M € | -8.5% | 5,4 M € | +42.0% | 3,8 M € | -24.9% | 5,1 M € | +19.8% | 4,2 M € | +51.2% | 2,8 M € | -29.2% | 4,0 M € | -39.4% | 6,5 M € | +186.4% | 2,3 M € | -16.0% | 2,7 M € | -30.4% | 3,9 M € | +10.2% | 3,5 M € | +10.6% | 3,2 M € | -20.2% | 4,0 M € | +142.7% | 1,7 M € | -57.4% | 3,9 M € | +125.4% | 1,7 M € | +10.4% | 1,6 M € | -16.1% | 1,9 M € | +38.6% | 1,3 M € | |
| Cash | 164,1 k € | -28.8% | 230,6 k € | +61.7% | 142,6 k € | +41.3% | 100,9 k € | +422.0% | 19,3 k € | -75.7% | 79,7 k € | -93.8% | 1,3 M € | +4278.0% | 29,4 k € | -20.6% | 37,0 k € | -65.2% | 106,3 k € | +492.7% | 17,9 k € | -88.2% | 152,0 k € | +1522.9% | 9,4 k € | -97.6% | 384,1 k € | -4.9% | 403,7 k € | -44.1% | 722,1 k € | +645.1% | 96,9 k € | +68.7% | 57,5 k € | +74.8% | 32,9 k € | -17.3% | 39,7 k € | |
| Debts | 3,8 M € | -14.4% | 4,4 M € | +53.0% | 2,9 M € | -32.0% | 4,2 M € | +26.0% | 3,4 M € | +70.3% | 2,0 M € | -37.5% | 3,2 M € | -44.8% | 5,7 M € | +276.8% | 1,5 M € | -22.2% | 1,9 M € | -39.5% | 3,2 M € | +7.7% | 3,0 M € | +19.3% | 2,5 M € | -29.5% | 3,6 M € | +194.9% | 1,2 M € | -67.2% | 3,7 M € | +185.4% | 1,3 M € | +9.4% | 1,2 M € | -24.4% | 1,6 M € | +41.4% | 1,1 M € | |
Public limited company · Kontich · incorporated on 27/07/1995
Public limited company profitable and well capitalised. Cash position declining (-28.8%).
Solid counterparty for a standard engagement.
Chr. Olesen is a Public limited company incorporated in 1995. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Kontich.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette